Researchers conducted a retrospective cohort study examining adults with opioid-use disorder undergoing buprenorphine initiation and the treatment’s association with precipitated withdrawal.
The estimated adjusted vaccine effectiveness was 91%. (HealthDay News) — Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract ...